We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cellular Dynamics Announces Presentations at the SOT Annual Meeting

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Cellular Dynamics International, Inc. has announced scientific presentations at the Society of Toxicology’s 53nd Annual Meeting (SOT), March 23 to 27 in Phoenix.

Key points:
• Multiple presentations, symposia and workshops demonstrate the expanding utility of CDI’s iCell® products on toxicology assay development.
• Several presentations describe research in the area of environmental toxicology; this highlights the expanding utility of CDI’s iCell and MyCell® Products outside of their traditional use in pharmaceutical toxicity testing and basic human biological research.

Quote:
Chris Parker, chief commercial officer of CDI said, “Our pharmaceutical and life science customers continue to find new ways to apply our iCell and MyCell Products to their drug development and research priorities. What is especially exciting for us is the increasing use of our cells outside of the life sciences. Several presenters at this year’s SOT meeting describe environmental toxicology applications for our cells. Along with our recently announced collaboration with Nestlé, who are using our cells for nutritional research, the application of our cells in multiple scientific disciplines validates CDI’s scientific and commercial mission.”

Environmental Toxicology Presentations:
“Induced Pluripotent Stem Cell-derived Neurons as a Human Model for Testing Environmentally-induced Developmental Neurotoxicity,” presented by IL Druwe, US EPA, within the “Induced Human Pluripotent Stem Cells and Their Differentiated Progeny Cells: Implementation in Toxicity Testing” symposium, March 24, 9:15 am - 12:00 p.m.

“Phenotypic In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using Human iPSC-derived Cardiomyocytes,” exhibitor-hosted session presented by CDI on NIEHS/NIH and pharmaceutical toxicity testing data, March 25, 1:30 - 2:30 pm.

“In Vitro Assessment of Cardiotoxicity Hazard of Environmental Compounds Using Fast Fluorescence Imaging of Beating iPSC-derived Cardiomyocytes,” poster presented by O Sirenko on NIEHS/NIH data, March 26, 9:00 am - 12:30 pm, Abstract 1616g.